Sustained cannabis use does not predispose clinical hypertension: Findings from a national survey

Shah, Rohan; Patel, Shiv; Shah, Sareena; Doshi, Sahil; Li, Angela; Diamond, Joseph A.

doi:10.1111/jch.14623

Cited by 4 publications

(2 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although some studies found associations between chronic diseases, for example, hypertension and diabetes mellitus, and risk of or worsening depression, 27,28 our data did not show any significant associations between presence of chronic diseases and worsening depression risk. Our relatively small sample size might be partly accountable for that.…”

Section: Discussioncontrasting

confidence: 98%

Smoking and Depression Risk Reduction in a Primary Care Setting

Mahmood,

Goldstein,

Thiele

et al. 2023

J Prim Care Community Health

View full text Add to dashboard Cite

Introduction: Smoking is associated with many diseases and is a target for primary preventive efforts in numerous morbidities. Studies show that smoking and depression may be associated. Never-smokers are at significantly lower risk than current and former smokers. Despite this observation, the effect of smoking on depression risk reduction has not been adequately explored. The purpose of this study was to explore the effect of smoking on depression risk reduction in adult patients seen in a primary care clinic at an academic medical center 6 months after they were identified as being at risk for depression. Findings may influence the direction and intensity of our smoking cessation endeavors in patients at risk of depression who smoke. Methods: We conducted an analytic cross-sectional study using electronic medical records of patients 18 years and older seen a primary care setting between January 1, 2019 and December 31, 2020. All participants included had an initial depression risk score (assessed by the 9-item Patient Health Questionnaire (PHQ-9)) of 5 or higher, information on smoking status and a PHQ-9 score at 6 months. We determined the percentage of patients with PHQ-9 score decrease of 5 or more at 6 months and used logistic regression to determine the association depression risk reduction (of 5 units or more) at 6 months and smoking, adjusting for demographic, clinical, and behavioral characteristics. Results: Number of patients included were 120, mean age was 55 (16), years, 88 (74%) were female, 68 (57%) were African American, and 31 (26%) were Caucasian. Fifty (44%) had a history of smoking and 31 (25.8%) had improvement (ie, a decrease of 5 units or more) in their PHQ-9 score at 6 months. Smoking was associated with decreased odds of improvement in depressive symptoms (Odds ratio = 0.32, 95% Confidence interval: 0.12-0.87). Conclusion: Risk of depression was more likely to persist in smokers than non-smokers at 6 months. Addressing smoking behavior in those with risk of depression may be beneficial.

show abstract

Section: Discussioncontrasting

confidence: 98%

Smoking and Depression Risk Reduction in a Primary Care Setting

Mahmood,

Goldstein,

Thiele

et al. 2023

J Prim Care Community Health

View full text Add to dashboard Cite

show abstract

“…For diagnosing dengue fever the Platelets indices were used as predictive markers because they show sensitivity to dengue fever. Due to decreased production of platelets in the bone marrow or increased destruction and clearance of platelets from peripheral blood were considered as the main cause of low platelet count in Dengue patients 36 .…”

Section: Discussionmentioning

confidence: 99%

Significance of Platelets and its Indices in Patients with Dengue Fever

Zeb¹,

Qaisar²,

Babar³

et al. 2023

PJMHS

View full text Add to dashboard Cite

Background: Dengue is a viral infection affecting different parts of the world, particularly the under developed countries including Pakistan. Changes in hematological parameters are frequently observed in dengue viral infection out of which the changes in the structure of platelets and their levels are a predominant factor in dengue viral infection. In view of the foresaid, this study was conducted to find the platelet levels and indices in confirmed cases suffering from dengue fever. Methods: This descriptive cross-sectional study was conducted in Peshawar in a duration of five months from September to December 2022. A total of five hundred patients were screened for dengue viral infection. Blood samples were collected from all suspected dengue infected patients and processed for complete blood count (CBC). Percentage and mean standard deviation were calculated and data were expressed in tables and graphs. Results: Among total suspected patients, one hundred fifty patients were found positive in which highest number of patients were male (65.3%) than female patients (34.7%). The minimum hemoglobin, white blood cells, and platelets were 6.9 g/dl, 2400 g/dl, and 43000 g/dl respectively. Low level of hemoglobin was found in 9.4% patients, 25.3% patients had below normal white blood cell count, and 30.4% patients were observed with less than normal platelet count. Few patients were noted with lower mean platelets volume and plateletcrit than normal. Conclusion: The study showed a significant impact of dengue viral infection on complete blood count. The hemoglobin, WBC, platelets, and platelet indices were potentially affected with dengue viral infection. It is necessary to design a strategy for early diagnosis of dengue infected patients for timely treatment, which can together save patients from severe impact of dengue viral infection such as dengue shock syndrome which could be fatal. Keywords: Dengue viral infection, Hematological parameters, Platelets, Mean Platelets Volume, Plateletcrit, Platelet distributive width.

show abstract

Trends in Cannabis Use, Blood Pressure, and Hypertension in Middle-Aged Adults: Findings From NHANES, 2009–2018

Corroon

Grant

Bradley

et al. 2023

American Journal of Hypertension

View full text Add to dashboard Cite

Background Observational studies investigating associations between cannabis use and blood pressure/hypertension are inconsistent. Methods Cross-sectional data from the NHANES were analyzed for five 2-year cycles between 2009 to 2018 representing 9,783 middle-aged adults (35-59 years). Hypertension was defined as SBP ≥ 130, DBP ≥ 80 or a blood pressure medication. Sample-weighted multivariable logistic regression models were used to assess associations between cannabis use and blood pressure and hypertension. Results One quarter of respondents (n=2,228) reported a history of monthly cannabis use for more than one year, which was consistent over the study period (p for trend = 0.75). Approximately 48% (n=4,831) met the definition of hypertension. While a significant positive trend was seen over time for mean SBP and DBP (p = < 0.01 for both), no significant trend was seen in prevalent hypertension (p for trend = 0.23). In adjusted models, compared to never use, a history of monthly cannabis use for more than one year was not associated with increased blood pressure (mean SBP: 124.5 mmHg (95% CI: 122.4 to 126.6) v. 122.6 (95% CI: 120.9 to 124.2);DBP: 74.7 mmHg (95% CI: 73.1 to 76.2) v. 74.1 (95% CI: 72.8-75.4)), or prevalent hypertension (OR=0.88 (95% CI: 0.62-1.24)). Results from analyses of duration of monthly use, and recency and frequency of recent use were similar. Conclusions A history of monthly cannabis use for more than one year was not independently associated with either increased blood pressure or prevalent hypertension in a nationally representative sample of middle-aged US adults.

show abstract

Sustained cannabis use does not predispose clinical hypertension: Findings from a national survey

Cited by 4 publications

References 21 publications

Smoking and Depression Risk Reduction in a Primary Care Setting

Smoking and Depression Risk Reduction in a Primary Care Setting

Significance of Platelets and its Indices in Patients with Dengue Fever

Trends in Cannabis Use, Blood Pressure, and Hypertension in Middle-Aged Adults: Findings From NHANES, 2009–2018

Contact Info

Product

Resources

About